Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2022 Results Conference Call November 9, 2022 4:30 PM ET

Company Participants

Kyle Gutsadt - Investor Relations

Joseph Payne - President and Chief Executive Officer

Andrew Sassine - Chief Financial Officer

Padmanabh Chivukula - Chief Scientific Officer and Chief Operating Officer

Conference Call Participants

Seamus Fernandez - Guggenheim

Yigal Nochomovitz - Citi

Pete Stavropoulos - Cantor Fitzgerald

Yale Jen - Laidlaw and Company

Yanan Zhu - Wells Fargo Securities

Operator

Good day ladies and gentlemen and welcome to the Arcturus Therapeutics Third Quarter 2022 Earnings Call. Today’s conference is being recorded.

At this time, I would like to turn the conference over to Kyle Gutsadt, Senior Analyst, Investor & Public Relations. Please go ahead, sir.

Kyle Gutsadt

Thank you, Keith. Good afternoon and welcome to Arcturus Therapeutics third quarter 2022 financial update and pipeline progress call. Thank you all for joining us. Today’s call will be led by Joseph Payne, our President and CEO; and Andy Sassine, our CFO. Dr. Pad Chivukula, our CSO and COO, will join in for the Q&A session.

Before we begin, I would like to remind everyone that, statements made during this call regarding matters that are not historical facts are forward-looking statements within the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties, and assumptions that may cause actual results, performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, performance, and achievements to differ materially from those expressed or implied by the statement.

Please see the forward-looking statement disclaimer on the company’s press release issued earlier today, as well as the risk factors section in our Forms 10-Q and 10-K filed with the SEC. In addition, any forward-looking statements represent our views only as of the date such statements are made, May 9, 2022. Arcturus specifically disclaims any obligation to update such statements to reflect future information, events or circumstances.

And with that, I will now turn the call over to Joe.

Joseph Payne

Thank you and good afternoon to all. Thank you for joining our tourist’s Q3 quarterly call. The recent period has been characterized by remarkable progress we have made both with our pipeline and also in completing transformational business development agreements with CSL and BARDA.

I will begin with our recently announced collaboration with CSL. I want to first express my gratitude to the entire team here at Arcturus that worked tirelessly on this deal, particularly the deal team led by Lance Carta, our Chief Legal Officer and Kevin Skull, who leads our Business Development Efforts. They all did an exceptional job. Indeed, there is an extraordinary story behind every extraordinary deal, so thank you to the team, many of which are listening to the call.